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Introduction  
In vivo 13C NMR spectroscopy in conjunction with the administration of 13C labeled substrates has 
been intensively used to assess cerebral metabolism in human and rat. 13C MRS studies of 
transgenic mouse models will provide insights into the metabolism in brain pathologies. However, 
the intrinsically low sensitivity of 13C MRS and the small size of the mouse brain remain limiting 
factors for measuring 13C labeling into metabolites in vivo, hence, most 13C MRS studies in mouse 
brain were achieved by using extracts [1]. Alternatively, the indirect detection of 13C through 1H 
combined with [1,6-13C2] or [U-13C6] glucose administration can improve the sensitivity and allow 
the direct measurement of fractional enrichments (FE). However, the distinct separation of 13C 
labeling in glutamate (Glu) and glutamine (Gln) using indirect detection requires sufficiently high 
spectral resolution [2,3]. Furthermore, due to the small blood volume of mouse, the input function 
from blood sampling during in vivo NMR experiments is hardly feasible, and thus the metabolic 
fluxes derived from in vivo measured turnover curves remain to be determined. In the present study, 
a short-TE full-sensitivity 1H-[13C] NMR sequence[3] combined with high magnet field (14T) was 
used to enhance the sensitivity and spectral dispersion which allows measuring separated GluC4, 
GlnC4, GlxC3 time courses in mouse brain with [U-13C6] glucose infusion and the further 
assessment of metabolic fluxes. 
Materials and Methods  
Animal: Four male ICR (CD-1) mice (34-36g) were fasted over 7 
hours and anesthetized using isoflurane (1.5-2%). One femoral vein 
was cannulated for the infusion of [U-13C6] glucose. After giving a bolus of 99%-enriched [U-13C6] glucose over 5 min, 
67%-enriched [U-13C6] glucose was infused continuously for up to four hours.  
NMR spectroscopy: All MRS experiments were perfromed on a 14.1T/26cm magnet (Varian/Magnex) using a homebuilt 13C 
/1H surface coil. 1H-[13C] spectra were acquired using a previously proposed full signal intensity 1H-[13C] NMR sequence 
‘SPECIAL-BISEP’[3], which was a hybrid sequence composed of a preceding 13C editing block based on the inversion 
BISEP and a spin-echo coherence-based localization. 13C editing was achieved by turning on and off the AFP in the 13C 
channel on alternate scans and the difference spectrum contained 13C coupled 1H resonances.OVS and VAPOR [4] water 
suppression were applied prior to SPECIAL-BISEP to suppress water signal and lipid contamination in 1H NMR spectra. 
FASTMAP was used to optimize B0 inhomogeneity and resulting in water linewidth of 21-24 Hz for a volume of 60μl 
containing cerebral cortex and striatum. Adiabatic 13C decoupling was applied during 145 ms acqusition time. 13C-edited and 
non-edited spectra were acquired with 8 scans in an interleaved mode and TR was 4 s.  
Data analysis: Spectra were quantified with LCModel [5] and fractional enrichment of metabolites was calculated directly 
from the relative ratio of the concentration obtained from difference spectra and that obtained from non-edited 1H spectra 
(AFP off). Under the isoflurane anesthesia, lactate (Lac) can be detected in 1H-[13C] NMR spectra. Given that rapid activity 
of lactate dehydrogenase allowing fast exchange between pyruvate and lactate, turnover of LacC3 is mimicking that of 
pyruvate and thus used as the input function for the metabolic model. One compartment metabolic model (glutamatergic 
neuron) [6] was used to fit the measured 13C labeling time courses of metabolites (i.e.GluC4, GlnC4, GlxC3) to calculate the 
metabolic fluxes and the reliability of the fitting was evaluated by Monte-Carlo simulation.   
Results and Discussion  
Non-edited and difference proton spectra acquired 
from the VOI of 60μl using SPECIAL-BISEP at 14T 
demonstrate a high signal-to-noise ratio and spectral 
resolution (Fig.1), e.g. the separation of GluC4 and 
GlnC4. 13C labeling in Glu, Gln, GABA, Asp, Glc, Ala and Lac was detected as shown in 
Fig.1. Note that 13C labeling into Glc and Lac can already be observed during the second 5 
min acquisition after the start of [U-13C6] glucose infusion. Subsequently, carbon positions of 
Glu, Gln and GABA were labeled, respectively (Fig1, Fig2). The average fractional 
enrichment curves of GluC4, GlnC4, GlxC3 from 4 mice were fitted using LacC3 as the input 
function (Fig.3) and resulted in values of neuronal TCA cycle flux VTCA(N) = 0.93 ± 0.03 
μmol/g/min (mean ± sd), which is similar to the results obtained from mouse brain extracts [7]. 
Additionally, the exchange flux between 2-oxoglutarate and glutamate Vx = 0.78 ± 0.04 
μmol/g/min and the Glu-Gln cycle flux VNT = 0.21 ± 0.01 μmol/g/min were obtained.  
 
We conclude that high quality 1H-[13C] NMR spectra can be acquired from a volume as small 
as 60μl in mouse brain in vivo at 14T. This allows us to obtain 13C labeling turnover curves of 
GluC4, GlnC4, GlxC3 with time resolution of ~ 5 min as well as LacC3 which offers 
precursor information to determine metabolic fluxes without additional blood sampling. The metabolic fluxes were obtained for the first time using in 
vivo measured turnover curves in mouse brain. This study can be extended to transgenic mouse models for further investigation of brain pathologies. 
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Fig.3: Fits and average time-resolved 13C fractional 
enrichment curves of GluC4, GlnC4, GlxC3 and LacC3.  
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Fig.1: Averaged non-edited (top) and difference 
(bottom) 1H NMR spectra acquired in the mouse 
brain during first hour of 67% [U-13C6] glucose 
infusion. (VOI = 60μl, nt = 960, no apodization 
was applied). Asp, aspartate; Glc, glucose; 
GABA, γ-aminobutyric acid; Ala, alanine; tCr, 
total creatine; Glx, Glu+Gln.
Fig.2: 13C labeling incorporation into 
Glc, LacC3, GluC4, GlnC4, GlxC3, 
GlxC2, AlaC3 during the first 90 
minutes of [U-13C6] glucose infusion 
with time resolution of ~ 5min. 
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